Neotherix CEO Dr Mike Raxworthy will be speaking at the World Conference on Regenerative Medicine 2015, to be held in Leipzig, Germany on 21-23 October. The interdisciplinary conference, which is typically attended by around 1,000 delegates, covers a broad range of regenerative medicine topics including biomaterials and tissue interaction, cell therapies, models of regeneration, tissue engineering and regulatory affairs.
Mike's presentation will be given during the Muscle, Skin, and Soft Tissue Regeneration session on Day 3 of the conference, 23 October, and will focus on the translation of our EktoTherix™ tissue repair scaffold "from test rig to clinic". The presentation will describe the pathway travelled and the learning gained by Neotherix during the development of EktoTherix. The product is currently being evaluated in a First in Man clinical safety study which is, to the best of our knowledge, the first full clinical investigation of a bioresorbable electrospun scaffold.
For more information, please see the World Conference on Regenerative Medicine web page .